{"success":true,"data":{"pressRelease":{"id":"35168","rtpr_id":"nGNX8cDrSF","ticker":"IBRX","exchange":"NASDAQ","all_tickers":["IBRX"],"title":"IMMUNITYBIO, INC. INVESTORS WITH LOSSES HAVE UNTIL MAY 26, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline","author":"Globe Newswire","published_at":"2026-05-14T13:14:00.420Z","article_body":"NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a\nnationally acclaimed investor rights law firm, reminds ImmunityBio, Inc.\n(“ImmunityBio” or the “Company”) (NASDAQ: IBRX) investors of the May\n26, 2026 deadline involving a securities fraud class action lawsuit commenced\nagainst the Company.\n\nShould You Join The ImmunityBio Class Action Lawsuit\n(https://www.globenewswire.com/Tracker?data=FIgMX4JtiaioZV9TcPbD9yiMCAaV5jit267v994HUVbV1w9VJkxbMR7SDuT1fbn71UCIHpuxCihrTfOQojc-JIu0P7PRBz8nQyYYeUia1H45NeFEjV5HOaGSpUsLggQI5i6Bn9FPH6pAy4qPaXuGSstkZs-xtvF1Gsn2TWrIAtDVMxQvrd5Ikt0YWOejeQeGL0iWSBKoN7L4P85exXqL4Q==):\n* Do you, or did you, own shares of ImmunityBio, Inc. (NASDAQ: IBRX)?\n\n* Did you purchase your shares between January 19, 2026 and March 24, 2026,\ninclusive?\n\n* Did you lose money in your investment in ImmunityBio, Inc.?\nIf you purchased or acquired ImmunityBio securities, and/or would like to\ndiscuss your legal rights and options please visit ImmunityBio, Inc.\nShareholder Class Action Lawsuit\n(https://www.globenewswire.com/Tracker?data=FIgMX4JtiaioZV9TcPbD9wswKKJxK2AhPZPMintXydN4FhXzpmNq0hVnvFzoAQDLWD1zGW8I_exY8n2PE07FrqIvjVhA6WkgBgzzk6qyiFEIeP70FS-NqOOEl082crIXPC-wxs-oahbbol1lI6hpQTRhRWy6KJIjZPl6Mxo8Kk1-iZu15KMpOwVKyR2zA4gAYa-hx3jNYPxdortUvn7QoA8V3BdPECeFgZ6wpd3wWl8ZZU84kW-bzVjz3WlDqgPl)\nor contact Investor Relations Manager Peter Allocco at (212)\n951-2030 or pallocco@bernlieb.com.\n\nIf you wish to serve as lead plaintiff for the Class, you must file papers by\nMay 26, 2026. A lead plaintiff is a representative party acting on other class\nmembers’ behalf in directing the litigation. Your ability to share in any\nrecovery doesn’t require that you serve as lead plaintiff. If you choose to\ntake no action, you may remain an absent class member.\n\nAll representation is on a contingency fee basis. Shareholders pay no fees or\nexpenses.\n\nAbout The Lawsuit:\n\nA lawsuit was filed on behalf of investors (the “Class”) who purchased or\nacquired the securities of ImmunityBio between January 19, 2026 and March 24,\n2026, inclusive, alleging violations of the Securities Exchange Act of 1934\nagainst the Company and certain of its senior officers.\n\nThe lawsuit alleges that defendants made materially false and misleading\nstatements and omissions regarding the Company’s business operations, growth\nprospects, and financial stability. As a result of these alleged\nmisrepresentations, ImmunityBio securities traded at artificially inflated\nprices during the Class Period. When the truth was disclosed, investors\nallegedly suffered significant losses.\n\nAbout Bernstein Liebhard:\n\nSince 1993, Bernstein Liebhard LLP\n(https://www.globenewswire.com/Tracker?data=ygrIcp6T96dJbS_KzHmHLMgbPhn91_dWg_CTXjfKP69BkQgzFuhUE5KaLJa2WNUO3A3hUzDUBAfg_-zEHjWyHzl6wZmi7-p9aTL1hWaaijA=)\nhas recovered over $3.5 billion for its clients. In addition to representing\nindividual investors, the Firm has been retained by some of the largest public\nand private pension funds in the country to monitor their assets and pursue\nlitigation on their behalf. As a result of its success litigating hundreds of\nclass actions, the Firm has been named to The National Law Journal’s\n“Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for\nsixteen consecutive years.\n\nATTORNEY ADVERTISING. © 2026 Bernstein Liebhard LLP. The law firm responsible\nfor this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New\nYork, New York 10016, (212) 779-1414. Prior results do not guarantee or\npredict a similar outcome with respect to any future matter.\n\nContact Information:\n\nPeter Allocco\nInvestor Relations Manager\nBernstein Liebhard LLP\nhttps://www.bernlieb.com\n(212) 951-2030\npallocco@bernlieb.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/5d514042-8326-4555-8ad7-f6cc765ecfcd)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX8cDrSF","title":"IMMUNITYBIO, INC. INVESTORS WITH LOSSES HAVE UNTIL MAY 26, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline","author":"Globe Newswire","ticker":"IBRX","created":"2026-05-14T13:14:00.420Z","tickers":["IBRX"],"exchange":"NASDAQ","article_body":"NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a\nnationally acclaimed investor rights law firm, reminds ImmunityBio, Inc.\n(“ImmunityBio” or the “Company”) (NASDAQ: IBRX) investors of the May\n26, 2026 deadline involving a securities fraud class action lawsuit commenced\nagainst the Company.\n\nShould You Join The ImmunityBio Class Action Lawsuit\n(https://www.globenewswire.com/Tracker?data=FIgMX4JtiaioZV9TcPbD9yiMCAaV5jit267v994HUVbV1w9VJkxbMR7SDuT1fbn71UCIHpuxCihrTfOQojc-JIu0P7PRBz8nQyYYeUia1H45NeFEjV5HOaGSpUsLggQI5i6Bn9FPH6pAy4qPaXuGSstkZs-xtvF1Gsn2TWrIAtDVMxQvrd5Ikt0YWOejeQeGL0iWSBKoN7L4P85exXqL4Q==):\n* Do you, or did you, own shares of ImmunityBio, Inc. (NASDAQ: IBRX)?\n\n* Did you purchase your shares between January 19, 2026 and March 24, 2026,\ninclusive?\n\n* Did you lose money in your investment in ImmunityBio, Inc.?\nIf you purchased or acquired ImmunityBio securities, and/or would like to\ndiscuss your legal rights and options please visit ImmunityBio, Inc.\nShareholder Class Action Lawsuit\n(https://www.globenewswire.com/Tracker?data=FIgMX4JtiaioZV9TcPbD9wswKKJxK2AhPZPMintXydN4FhXzpmNq0hVnvFzoAQDLWD1zGW8I_exY8n2PE07FrqIvjVhA6WkgBgzzk6qyiFEIeP70FS-NqOOEl082crIXPC-wxs-oahbbol1lI6hpQTRhRWy6KJIjZPl6Mxo8Kk1-iZu15KMpOwVKyR2zA4gAYa-hx3jNYPxdortUvn7QoA8V3BdPECeFgZ6wpd3wWl8ZZU84kW-bzVjz3WlDqgPl)\nor contact Investor Relations Manager Peter Allocco at (212)\n951-2030 or pallocco@bernlieb.com.\n\nIf you wish to serve as lead plaintiff for the Class, you must file papers by\nMay 26, 2026. A lead plaintiff is a representative party acting on other class\nmembers’ behalf in directing the litigation. Your ability to share in any\nrecovery doesn’t require that you serve as lead plaintiff. If you choose to\ntake no action, you may remain an absent class member.\n\nAll representation is on a contingency fee basis. Shareholders pay no fees or\nexpenses.\n\nAbout The Lawsuit:\n\nA lawsuit was filed on behalf of investors (the “Class”) who purchased or\nacquired the securities of ImmunityBio between January 19, 2026 and March 24,\n2026, inclusive, alleging violations of the Securities Exchange Act of 1934\nagainst the Company and certain of its senior officers.\n\nThe lawsuit alleges that defendants made materially false and misleading\nstatements and omissions regarding the Company’s business operations, growth\nprospects, and financial stability. As a result of these alleged\nmisrepresentations, ImmunityBio securities traded at artificially inflated\nprices during the Class Period. When the truth was disclosed, investors\nallegedly suffered significant losses.\n\nAbout Bernstein Liebhard:\n\nSince 1993, Bernstein Liebhard LLP\n(https://www.globenewswire.com/Tracker?data=ygrIcp6T96dJbS_KzHmHLMgbPhn91_dWg_CTXjfKP69BkQgzFuhUE5KaLJa2WNUO3A3hUzDUBAfg_-zEHjWyHzl6wZmi7-p9aTL1hWaaijA=)\nhas recovered over $3.5 billion for its clients. In addition to representing\nindividual investors, the Firm has been retained by some of the largest public\nand private pension funds in the country to monitor their assets and pursue\nlitigation on their behalf. As a result of its success litigating hundreds of\nclass actions, the Firm has been named to The National Law Journal’s\n“Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for\nsixteen consecutive years.\n\nATTORNEY ADVERTISING. © 2026 Bernstein Liebhard LLP. The law firm responsible\nfor this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New\nYork, New York 10016, (212) 779-1414. Prior results do not guarantee or\npredict a similar outcome with respect to any future matter.\n\nContact Information:\n\nPeter Allocco\nInvestor Relations Manager\nBernstein Liebhard LLP\nhttps://www.bernlieb.com\n(212) 951-2030\npallocco@bernlieb.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/5d514042-8326-4555-8ad7-f6cc765ecfcd)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-05-14T13:14:00.493749334Z","server_sent_at_ms":1778764440493},"received_at":"2026-05-14T13:14:00.550Z","source_url":null},"analysis":null,"durationMs":null,"modelName":null}}